Results of surgical management of XXXX metastatic to the pancreas.

@entity1 @entity5 @entity260 @entity1358 @entity3
AIM OF THE STUDY: Metastases from @entity1358 represent between 0.25% and 3.00% of all resected @entity5 . The aim of this study was to review 13 @entity1 with @entity1358 metastatic to the pancreas. MATERIAL AND METHODS: Clinical data, time from initial presentation, operative outcome, long-term survival, @entity5 size, presence of lymphatic invasion, and surgical margin status were evaluated. RESULTS: The median age of the @entity1 was 62 years (mean 60.9). The median time for appearance of @entity3 following resection of the primary @entity5 was 9 years (mean 8.38). Pancreatic @entity3 were located in the head of the pancreas in four @entity1 , in the body in three, in the tail in two @entity1 , and four @entity1 had multiple pancreatic localisations. Four (30.7%) pancreatoduodenectomies, 5 (38.5%) distal resections, 2 (15.3%) total pancreatectomies, 1 (7.6%) enucleation, and 1 (7.6%) Roux duodenojejunostomy were performed. Two @entity1 (15.3%) had @entity260 . Operative mortality was 0%. Surgical margins were microscopically positive in 1 (8.3%) @entity1 , and lymph nodes were positive in 2 (16.6%) @entity1 . In our group of 7 deceased @entity1 the mean survival was 19 months (median 16 months). CONCLUSIONS: @entity1358 metastatic to the pancreas can occur several years after nephrectomy. In our series a large number of @entity1 with occurrence of symptoms, @entity5 , @entity3 to lymph node, and positive margin were connected with short survival period. Early detection of primary @entity5 , long and thorough @entity1 care, and radical resections give @entity1 a chance for a prolonged life.
